Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Burr and Burr PLC
LONDON, October 10, 2013 /PRNewswire/ --
Burr and Burr PLC closes £35 Million in acquisitions.
The Directors of Burr and Burr PLC are pleased to announce the completion of a series of brand acquisitions for the Omega 3 health supplement sector.
In addition and as part of the GO3 deal, Burr and Burr have enlisted the industry expertise of Geir Frantzen in order to draw a line in the sand with respect to the sector's consolidation that Burr and Burr have begun.
Mr Franzten, formerly a senior vice president and owner of Findus Group, has years of vital experience in the production and distribution of Omega 3 in multiple global markets. He brings vital strategy and growth planning to the brands owned by Burr and Burr. "I am very excited at this development and the chance to build the largest company in the field," said Mr Frantzen.
Chris Thornblom, interim CEO said, "We are well underway in our development phase and will continuously seek to acquire additional brands that have a strategic fit with our plan of becoming a leading player in the health supplement field. Additionally, assembling a team of exceptional individuals with strong leadership capabilities, a cohesive work ethic, and the industry expertise to move Burr and Burr's products through various distribution channels."
Burr and Burr boasts its all-natural product will outperform sales of drug versions sold by pharmaceutical companies, given the growing concerns about side effects around synthetic versions. To this end, the branding concept "THIS IS NOT A DRUG" was developed and is being trademarked by Burr and Burr.
"Financing the business was not the easiest and negotiations have been ongoing for over 12 months, but now its concluded I am happy to say it was worth it. We have brought together a number of private equity groups for phase one and now going into the next phase with extreme confidence" said Edward Fitzpatrick of Cazord Capital Limited.
About Burr and Burr
Burr and Burr is a London based health supplement business with a focus on Omega 3 products. Burr and Burr are consolidating the sector to create a series of brands that target all market segments for Omega 3 by offering the best quality product at the best possible price. With its mass marketing strategy and key acquisitions well under way Burr and Burr expects to sell tens of millions in product within the next 12 months becoming the largest distributor in the country before taking the strategy overseas.
Please visit http://www.burrandburr.com for more information about Burr and Burr and its brands.
Media Contact: CEO Chris Thornblom: firstname.lastname@example.org
©2012 PR Newswire. All Rights Reserved.